Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis
Archives of Biochemistry and Biophysics · 2023-09 · 745 · 109720
DOI: 10.1016/j.abb.2023.109720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023-09. Verfasst von Gui Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: 18790678933@163.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Beauvericin is a world-spread mycotoxin isolated from the traditional Chinese medicine, Bombyx batryticatus (BB), which has been widely used to treat various neoplastic diseases. This study investigated the anti-hepatocellular carcinoma (HCC) activity of beauvericin and its potential mechanism. In this study, H22-bearing mice were intraperitoneally injected with 3, 5, 7 mg/kg of beauvericin once per-week over a three-week period. TUNEL staining determined the extent of tumor apoptosis induced by beauvericin. ELISA kits detected the level of IL-2, Perforin, and TNF-α, IFN-γ level in the serum. H22 hepatoma cells were exposed to beauvericin (5, 10, and 20 μmol/L) to investigate the underlying pathway. CCK-8 assay was used to observe the influence of beauvericin on the growth of H22 cells. Flow cytometry was used to detect the cell apoptosis and ROS level. Western blotting was performed to detect apoptotic and PI3K/AKT pathway protein production. The results showed that beauvericin could remarkably inhibit the growth of HCC in mice, combined with elevated TNF-α and IL-2. In vitro, beauvericin significantly promoted the generation of ROS, up-regulated Bax/Bcl-2 ratio and cleaved caspase-9, cleaved caspase-3 levels, down-regulated p-PI3K/PI3K ratio, p-AKT/AKT ratio, promoted the apoptosis of H22 cells, and inhibited the growth of H22 cells. Remarkably, treatment with PI3K/AKT activator (740Y-P and SC79) could prevent beauvericin-induced H22 cell apoptosis. These findings collectively indicate that beauvericin inhibits HCC growth by inducing apoptosis via the PI3K/AKT pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: 18790678933@163.com.
- Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: qiaoyamei9393@163.com.
- Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: z1334173263@126.com.
- Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: syyeva95@163.com.
- Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: ywz11245968@163.com.
- Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: jinminzh@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, G., Qiao, Y., Zhao, Y., Song, Y., Li, M., Jin, M., Yang, D., Yin, J., Li, J., & Liu, W. (2023). Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis. Archives of Biochemistry and Biophysics, 745, 109720. https://doi.org/10.1016/j.abb.2023.109720
Vancouver
Wang G, Qiao Y, Zhao Y, Song Y, Li M, Jin M, et al. Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis. Archives of Biochemistry and Biophysics. 2023;745:109720. doi:10.1016/j.abb.2023.109720
BibTeX
@article{Wang2023,
author = {Wang, Gui and Qiao, Yamei and Zhao, Yunyan and Song, Yuanyuan and Li, Mengyang and Jin, Min and Yang, Dong and Yin, Jing and Li, Junwen and Liu, Weili},
title = {Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis},
journal = {Archives of Biochemistry and Biophysics},
year = {2023},
volume = {745},
pages = {109720},
doi = {10.1016/j.abb.2023.109720}
}
EUVIMED